The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
In a new Canadian Medical Association Journal (CMAJ) article, Dr. David Juurlink, head of Sunnybrook’s division of clinical pharmacology and toxicology, makes a case for judicious prescribing of cannabis to patients who report meaningful benefit from it. Read more: http://sunnybrook.ca/media/item.asp?c=1&i=1146&f=medical-marijuana-cannabis-juurlink
https://cannabisexaminers.com/wp-content/uploads/2019/02/3819/dr-juurlink-on-prescribing-medical-marijuana.jpg
In a new Canadian Medical Association Journal (CMAJ) article, Dr. David Juurlink, head of Sunnybrook’s division of clinical pharmacology and toxicology, makes a case for judicious prescribing of cannabis to patients who report meaningful benefit from it.
Read more: http://sunnybrook.ca/media/item.asp?c=1&i=1146&f=medical-marijuana-cannabis-juurlink